Actinomycin D for fibrosis management in ophthalmic implant surgery
Implants that feature a drug delivery system loaded with antifibrotic active drugs provide a promising approach to address postoperative complications caused by fibrosis. This study is intended to clarify whether Actinomycin D has an impact specifically on components of the extracellular matrix (ECM...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
De Gruyter
2019-09-01
|
| Colección: | Current Directions in Biomedical Engineering |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1515/cdbme-2019-0121 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|